Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alzheimer's disease
5
×
biogen
5
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
deals
5
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
5
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
cancer immunotherapy
pfizer
startups
aduro biotech
bristol-myers squibb
cancer
clinical trials
drug prices
eli lilly
gilead sciences
What
bio
roundup
drug
alzheimer’s
biogen’s
companies
crispr
nash
news
price
acquisitions
aducanumab
albert
alliance
amyloid
angst
approval
bagged
biggest
billions
biogen
biopharmaceutical
bourla
brammer
bristol
buy
calls
ceo
changing
color
company
convo
days
different
earlier
effects
fail
failure
failures
felt
Language
unknown
unset
Current search:
deals
×
national
×
" alzheimer's disease "
×
biogen
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More